Neuroscience Studies

Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain.

Researchers developed a synthetic polymer nano-system for delivering CBD to improve its effectiveness in treating neuroinflammation. This system shows promising results in restoring mitochondrial function in cells after ischemic events. Worth considering for preclinical studies.

Chevalier MT et al (2024).
Mol Pharm.
PubMed:
38412451

Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer's Disease.

Study investigated natural product curcumin's effectiveness in treating Alzheimer's disease. Curcumin has anti-amyloid & anti-inflammatory properties, but poor bioavailability. Novel formulations improve bioavailability, potential treatment option for AD.

Urmila A, Kundlik R and Mathure D (2024).
Cent Nerv Syst Agents Med Chem.
PubMed:
38409724

Sophora flavescens alcohol extract ameliorates insomnia and promotes PI3K/AKT/BDNF signaling transduction in insomnia model rats.

This study found that Sophora flavescens extract promotes deep sleep, reduces insomnia symptoms, and activates brain signaling pathways. It could be a potential treatment for insomnia.

Wu Y et al (2024).
Neuroreport.
PubMed:
38407863

Investigation of neuroprotective and therapeutic effects of cannabidiol in an acute coronary syndrome model.

Study shows CBD from Cannabis sativa protects brain from I/R injury in heart. Potential neuroprotective and therapeutic benefits. Worth exploring for organ damage prevention.

Dogan Unlu M et al (2024).
Neurosci Lett.
PubMed:
38401641

Treatment with Glycyrrhiza glabra Extract Induces Anxiolytic Effects Associated with Reduced Salt Preference and Changes in Barrier Protein Gene Expression.

GG extract reduced anxiety behavior and salt preference in rats under chronic stress conditions by altering gene expression of barrier proteins in the prefrontal cortex. GG may be a beneficial therapy for depression and anxiety disorders with high aldosterone levels and inflammation.

Murck H et al (2024).
Nutrients.
PubMed:
38398838

Levistilide A Exerts a Neuroprotective Effect by Suppressing Glucose Metabolism Reprogramming and Preventing Microglia Polarization Shift: Implications for Parkinson's Disease.

Levistilide A (LA) from Angelica sinensis decreases inflammation in microglia, protects neurons, and modulates glucose metabolism in Parkinson's disease, showing therapeutic promise.

Zhang M et al (2024).
Molecules.
PubMed:
38398662

Baccharis dracunculifolia DC Consumption Improves Nociceptive and Depressive-like Behavior in Rats with Experimental Osteoarthritis.

DC extract from Brazilian plant reversed chronic pain and emotional impairments in osteoarthritic rats. Contains anti-inflammatory compounds, potential for nutraceuticals and functional foods.

Laranjeira IM et al (2024).
Foods.
PubMed:
38397516